<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.napwa.org.au" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>maraviroc</title>
 <link>http://www.napwa.org.au/articles-by-tx/131</link>
 <description>Embedded view for the TXinfo ctype</description>
 <language>en-au</language>
<item>
 <title>Report from Rome - 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention</title>
 <link>http://www.napwa.org.au/2011/07/28/report-from-rome-6th-ias-conference-on-hiv-pathogenesis-treatment-and-prevention</link>
 <description> &lt;p&gt;The 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention was held in Rome last week from 17-20 July. This meeting is held every two years and alternates with the much larger World AIDS Conferences also organised by the International AIDS Society (IAS).&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/2011/07/28/report-from-rome-6th-ias-conference-on-hiv-pathogenesis-treatment-and-prevention&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/protease-inhibitors/atazanavir">atazanavir</category>
 <category domain="http://www.napwa.org.au/taxonomy/term/346">conference reports</category>
 <category domain="http://www.napwa.org.au/defeating-hiv/hiv-prevention">HIV prevention</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/integrase-inhibitors">integrase inhibitors</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/experimental-treatments/attachment-inhibitor">maraviroc</category>
 <category domain="http://www.napwa.org.au/nnrti">NNRTI</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/nnrtis">NNRTIs</category>
 <category domain="http://www.napwa.org.au/living-with-hiv/defeating-hiv/sex-and-relationships/hiv-prevention/pre-exposure-prophylaxis-prep">Pre-exposure prophylaxis (PrEP)</category>
 <enclosure url="http://www.napwa.org.au/image/view/2705/preview" length="13368" type="image/jpeg" />
 <pubDate>Wed, 27 Jul 2011 18:40:18 -0700</pubDate>
 <dc:creator>Graham Stocks</dc:creator>
 <guid isPermaLink="false">2703 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>Snippets from ASHM</title>
 <link>http://www.napwa.org.au/pl/2010/12/snippets-from-ashm</link>
 <description> &lt;p&gt;The Australasian HIV/AIDS Conference was held in Sydney in October. Here are some of the treatment highlights:&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/pl/2010/12/snippets-from-ashm&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/nrtis/abacavir">abacavir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/experimental-treatments/attachment-inhibitor">maraviroc</category>
 <category domain="http://www.napwa.org.au/treating-hiv/understanding-hiv-treatments/starting-treatments">starting treatments</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/ntrtis/tenofovir">tenofovir</category>
 <category domain="http://www.napwa.org.au/defeating-hiv/the-global-hiv-epidemic">The global HIV epidemic</category>
 <pubDate>Wed, 01 Dec 2010 17:34:41 -0800</pubDate>
 <dc:creator>Graham Stocks</dc:creator>
 <guid isPermaLink="false">2482 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>AIDS 2008: Is the HIV drug pipeline drying up?</title>
 <link>http://www.napwa.org.au/pl/2008/09/aids-2008-is-the-hiv-drug-pipeline-drying-up</link>
 <description> &lt;p&gt;The International AIDS Conference heard promising reports about the newer HIV treatments designed to help treat people with advanced and drug-&lt;a class=&quot;glossary-term&quot; href=&quot;/glossary/term/109&quot;&gt;&lt;span&gt;resistant&lt;/span&gt;&lt;/a&gt;&lt;span class=&quot;hovertip&quot;&gt;HIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistant.&lt;/span&gt; HIV, all of which are now available in Australia.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/pl/2008/09/aids-2008-is-the-hiv-drug-pipeline-drying-up&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/maturation-inhibitors/experimental-treatment">bevirimat (MPC-4326, PA-457)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/clinical-trials">clinical trials</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/protease-inhibitors/experimental-treatments-0">darunavir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/integrase-inhibitors/experimental-treatment-0">elvitegravir (GS-9137)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/nnrtis/experimental-treatments/etravirine-t">etravirine (TMC-125)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments">HIV treatments</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/experimental-treatments/attachment-inhibitor">maraviroc</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/integrase-inhibitors/experimental-treatments">raltegravir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/nnrtis/experimental-treatments/rilpivirine-">rilpivirine (TMC 278)</category>
 <enclosure url="http://www.napwa.org.au/image/view/868/preview" length="16012" type="image/jpeg" />
 <pubDate>Tue, 23 Sep 2008 19:21:56 -0700</pubDate>
 <dc:creator>David Menadue</dc:creator>
 <guid isPermaLink="false">869 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>IAS 2007: Promising signs</title>
 <link>http://www.napwa.org.au/pl/2007/10/ias-2007-promising-signs</link>
 <description> &lt;p&gt;A major HIV/AIDS medical conference in Sydney has generated lots of news on the treatments front, reports Paul Kidd.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/pl/2007/10/ias-2007-promising-signs&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/nrtis/abacavir">abacavir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/clinical-trials">clinical trials</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments">HIV treatments</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/integrase-inhibitors">integrase inhibitors</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/experimental-treatments/attachment-inhibitor">maraviroc</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/integrase-inhibitors/experimental-treatments">raltegravir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/understanding-hiv-treatments/starting-treatments">starting treatments</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/experimental-treatments/attachment-inhibito-2">vicriviroc</category>
 <enclosure url="http://www.napwa.org.au/image/view/1209/preview" length="21745" type="image/jpeg" />
 <pubDate>Sun, 14 Oct 2007 07:10:00 -0700</pubDate>
 <dc:creator>Paul Kidd</dc:creator>
 <guid isPermaLink="false">663 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>CROI 2007: A great leap forward</title>
 <link>http://www.napwa.org.au/pl/2007/03/croi-2007-a-great-leap-forward</link>
 <description> &lt;p&gt;A major scientific conference on HIV has wound up with promising news on treatments which could signal a significant improvement in HIV treatment for the first time in some years.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/pl/2007/03/croi-2007-a-great-leap-forward&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/cancers/anal-cancer">anal cancer</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/nnrtis/efavirenz">efavirenz</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/integrase-inhibitors/experimental-treatment-0">elvitegravir (GS-9137)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/nnrtis/experimental-treatments/etravirine-t">etravirine (TMC-125)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/heart-disease">heart disease</category>
 <category domain="http://www.napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/lipodystrophy-and-lipoatrophy">Lipodystrophy and lipoatrophy</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/protease-inhibitors/lopinavir">lopinavir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/experimental-treatments/attachment-inhibitor">maraviroc</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/integrase-inhibitors/experimental-treatments">raltegravir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/nnrtis/experimental-treatments/rilpivirine-">rilpivirine (TMC 278)</category>
 <enclosure url="http://www.napwa.org.au/image/view/785/preview" length="10736" type="image/jpeg" />
 <pubDate>Wed, 21 Mar 2007 07:10:12 -0700</pubDate>
 <dc:creator>Paul Kidd</dc:creator>
 <guid isPermaLink="false">606 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>ASHM 2006: Strategies for coping with multiple drug resistance</title>
 <link>http://www.napwa.org.au/pl/2006/12/ashm-2006-strategies-for-coping-with-multiple-drug-resistance</link>
 <description> &lt;p&gt;Finding effective treatment options for people who have taken many treatments and have multiple &lt;a class=&quot;glossary-term&quot; href=&quot;/glossary/term/109&quot;&gt;&lt;span&gt;resistance&lt;/span&gt;&lt;/a&gt;&lt;span class=&quot;hovertip&quot;&gt;HIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistant.&lt;/span&gt; mutations continues to be a significant challenge for &lt;span class=&quot;caps&quot;&gt;HIV&lt;/span&gt; clinicians, and their patients.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/pl/2006/12/ashm-2006-strategies-for-coping-with-multiple-drug-resistance&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/understanding-hiv-treatments/adherance">adherance</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/protease-inhibitors/experimental-treatments-0">darunavir</category>
 <category domain="http://www.napwa.org.au/understanding-hiv-treatments/treating-hiv/salvage-therapy/understanding-hiv-treatments/drug-resista">drug resistance</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/entry-inhibitors/t-20">enfuvirtide (T-20)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/nnrtis/experimental-treatments/etravirine-t">etravirine (TMC-125)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/experimental-treatments/attachment-inhibitor">maraviroc</category>
 <category domain="http://www.napwa.org.au/treating-hiv/understanding-hiv-treatments/salvage-therapy">salvage therapy</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/protease-inhibitors/experimental-treatments">tipranavir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/experimental-treatments/attachment-inhibito-2">vicriviroc</category>
 <pubDate>Wed, 20 Dec 2006 06:07:10 -0800</pubDate>
 <dc:creator>Paul Kidd</dc:creator>
 <guid isPermaLink="false">596 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>Time to deliver</title>
 <link>http://www.napwa.org.au/pl/2006/10/time-to-deliver</link>
 <description> &lt;p&gt;The 16th International &lt;span class=&quot;caps&quot;&gt;AIDS&lt;/span&gt; Conference highlighted numerous important and promising developments in &lt;span class=&quot;caps&quot;&gt;HIV&lt;/span&gt; treatments. &lt;span class=&quot;caps&quot;&gt;JOHN&lt;/span&gt; &lt;span class=&quot;caps&quot;&gt;DAYE&lt;/span&gt; reports.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/pl/2006/10/time-to-deliver&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/protease-inhibitors/experimental-treatments-1">brecanavir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/protease-inhibitors/experimental-treatments-0">darunavir</category>
 <category domain="http://www.napwa.org.au/understanding-hiv-treatments/treating-hiv/salvage-therapy/understanding-hiv-treatments/drug-resista">drug resistance</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/entry-inhibitors/t-20">enfuvirtide (T-20)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/entry-inhibitors">entry and fusion inhibitors</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/nnrtis/experimental-treatments/etravirine-t">etravirine (TMC-125)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/experimental-treatments/attachment-inhibito-3">ibalizumab (TNX-355)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/lipodystrophy-and-lipoatrophy">Lipodystrophy and lipoatrophy</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/experimental-treatments/attachment-inhibitor">maraviroc</category>
 <category domain="http://www.napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/peripheral-neuropathy">peripheral neuropathy</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/integrase-inhibitors/experimental-treatments">raltegravir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/mental-health/stress-depression-anxiet">stress, depression, anxiety</category>
 <category domain="http://www.napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/lipodystrophy-and-lipoatrophy/treatmen-0">uridine</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/experimental-treatments/attachment-inhibito-2">vicriviroc</category>
 <enclosure url="http://www.napwa.org.au/image/view/1217/preview" length="25518" type="image/jpeg" />
 <pubDate>Wed, 04 Oct 2006 07:10:48 -0700</pubDate>
 <dc:creator>John Daye</dc:creator>
 <guid isPermaLink="false">584 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>Much more than a junket</title>
 <link>http://www.napwa.org.au/pl/2005/10/much-more-than-a-junket</link>
 <description> &lt;p&gt;A report from the 3rd IAS Conference on HIV Pathogenesis and Treatment, held in Rio de Janiero in July.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/pl/2005/10/much-more-than-a-junket&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/protease-inhibitors/atazanavir">atazanavir</category>
 <category domain="http://www.napwa.org.au/taxonomy/term/346">conference reports</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/protease-inhibitors/experimental-treatments-0">darunavir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/entry-inhibitors">entry and fusion inhibitors</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/protease-inhibitors/lopinavir">lopinavir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/experimental-treatments/attachment-inhibitor">maraviroc</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/experimental-treatments/entry-inhibitors/pr">PRO-542</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/protease-inhibitors/ritonavir">ritonavir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/protease-inhibitors/experimental-treatments">tipranavir</category>
 <category domain="http://www.napwa.org.au/taxonomy/term/358">Brazil</category>
 <enclosure url="http://www.napwa.org.au/image/view/808/preview" length="14440" type="image/jpeg" />
 <pubDate>Wed, 12 Oct 2005 07:08:03 -0700</pubDate>
 <dc:creator>Paul Kidd</dc:creator>
 <guid isPermaLink="false">429 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>The bleeding edge</title>
 <link>http://www.napwa.org.au/pl/2005/04/the-bleeding-edge</link>
 <description> &lt;p&gt;The annual Retrovirus Conference is a key event on the HIV scientific calendar, and regularly highlights  the most exciting &amp;lsquo;bleeding edge&amp;rsquo; developments from the world of HIV science.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/pl/2005/04/the-bleeding-edge&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/experimental-treatments/attachment-inhibito-1">aplaviroc (GSK-873,140)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/maturation-inhibitors/experimental-treatment">bevirimat (MPC-4326, PA-457)</category>
 <category domain="http://www.napwa.org.au/taxonomy/term/346">conference reports</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/protease-inhibitors/experimental-treatments-0">darunavir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/diabetes">diabetes</category>
 <category domain="http://www.napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/heart-disease">heart disease</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments">HIV treatments</category>
 <category domain="http://www.napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/lipodystrophy-and-lipoatrophy">Lipodystrophy and lipoatrophy</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/experimental-treatments/attachment-inhibitor">maraviroc</category>
 <category domain="http://www.napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/lipodystrophy-and-lipoatrophy/treatment">polylactic acid</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/nnrtis/experimental-treatments/rilpivirine-">rilpivirine (TMC 278)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/sexually-transmissible-infections">sexually-transmissible infections</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/experimental-treatments/attachment-inhibito-0">TAK-652</category>
 <category domain="http://www.napwa.org.au/treating-hiv/symptoms-illnesses-and-opportunistic-infections/treatment-side-effects">treatment side effects</category>
 <enclosure url="http://www.napwa.org.au/image/view/820/preview" length="52180" type="image/jpeg" />
 <pubDate>Wed, 18 May 2005 07:00:25 -0700</pubDate>
 <dc:creator>John Daye</dc:creator>
 <guid isPermaLink="false">149 at http://www.napwa.org.au</guid>
</item>
</channel>
</rss>

